Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CUR

Neuralstem (CUR) Stock Price, News & Analysis

Neuralstem logo

About Neuralstem Stock (NASDAQ:CUR)

Advanced Chart

Key Stats

Today's Range
$0.73
$0.76
50-Day Range
$0.67
$1.52
52-Week Range
$1.10
$13.78
Volume
68,732 shs
Average Volume
236,278 shs
Market Capitalization
$1.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neuralstem and its competitors with MarketBeat's FREE daily newsletter.

CUR Stock News Headlines

Aguas Da Curia Share Price (CUR.LS)
XAUUSD:CUR Gold Spot Price
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
4 Biotech Stocks Under $10 Moving Higher
XPTUSD:CUR Platinum Spot Price
XAUUSD:CUR
See More Headlines

CUR Stock Analysis - Frequently Asked Questions

Neuralstem, Inc. (NASDAQ:CUR) posted its earnings results on Wednesday, August, 14th. The company reported ($1.45) earnings per share for the quarter. The company earned $0.01 million during the quarter. Neuralstem had a negative trailing twelve-month return on equity of 170.51% and a negative net margin of 39,417.64%.

Neuralstem's stock reverse split before market open on Thursday, July 18th 2019.The 1-20 reverse split was announced on Tuesday, July 16th 2019. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 17th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neuralstem investors own include XOMA Royalty (XOMA), MannKind (MNKD), Cytokinetics (CYTK), Turkcell Iletisim Hizmetleri AS (TKC), Idera Pharmaceuticals (IDRA), SELLAS Life Sciences Group (SLS) and ACADIA Pharmaceuticals (ACAD).

Company Calendar

Last Earnings
8/14/2019
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:CUR
CIK
1357459
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.93 million
Net Margins
-39,417.64%
Pretax Margin
N/A
Return on Equity
-170.51%
Return on Assets
-110.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.53
Quick Ratio
2.53

Sales & Book Value

Annual Sales
$260 thousand
Price / Sales
6.18
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.64 per share
Price / Book
0.12

Miscellaneous

Outstanding Shares
2,100,000
Free Float
N/A
Market Cap
$1.61 million
Optionable
Not Optionable
Beta
1.81
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:CUR) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners